BMEYE(TM) Announces FDA 510(K) Clearance for Nexfin(TM)

    AMSTERDAM, Dec. 10 /CNW/ - BMEYE(TM) announced today that it has received
510(K) clearance from the U.S. Food and Drug Administration (FDA) to market
Nexfin(TM), their newly developed line of safe, precise and easy to use
hemodynamic monitors. The Nexfin(TM) monitors provide precise and easy to use
continuous non-invasive blood pressure and cardiac output monitoring.
BMEYE(TM) received CE market approval earlier this year.
    "BMEYE(TM) was established to develop and market innovative technology
that will transform the practice of medicine in hemodynamic patient
monitoring. The product launch of Nexfin(TM) in Europe earlier this year has
been very successful. We are eager to now launch Nexfin(TM) in the United
States. Cardiologists and any clinician who needs to measure continuous
non-invasive blood pressure and cardiac output easily and precisely will
benefit," said Bill Bednarski, CEO of BMEYE(TM). "The Nexfin(TM) is cost
effective and will significantly improve patient care."

    BMEYE(TM) develops and markets innovative medical technology with broad
applications in a variety of clinical settings. The focus of BMEYE(TM) is on
precise and easy to use non-invasive hemodynamic monitoring. The Nexfin(TM)
family of monitors use an easy to apply finger sensor to produce precise
continuous non-invasive blood pressure and cardiac output data displayed on an
intuitive touchscreen.

    Patents pending. For more information please check our web site at

For further information:

For further information: Bill Bednarski, CEO BMEYE, Academic Medical
Center, Suite K2-245, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands,
Phone: +31-(0)20-566-7720, Email:; Center for
Emerging Technologies, 4041 Forest Park Avenue, St. Louis, Missouri, 63108,
USA, Phone: (925) 270-0741

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890